{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Hoffmann-La Roche", "item": "https://www.patentleaderboard.com/company/hoffmann-la-roche"}, {"@type": "ListItem", "position": 3, "name": "Viktor Levitski", "item": "https://www.patentleaderboard.com/inventor/fl:vi_ln:levitski-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
VL

Viktor Levitski — 12 Patents

Hoffmann-La Roche: 10 patents #367 of 3,238Top 15%
HRHofmann-La Roche: 1 patents #2 of 42Top 5%
Schlieren, CH: #10 of 169 inventorsTop 6%
Overall (All Time): #396,045 of 4,157,543Top 10%
12 Patents All Time
Viktor Levitski has been granted 12 US patents while listed as an inventor at Hoffmann-La Roche. The first was granted in 2019 and the most recent in October 2025. Viktor Levitski ranks #396,045 of 4,157,543 US inventors in our database (top 9.5%). Patent records list Viktor Levitski in Schlieren, CH.

Patents per Year

Patents granted per year, 2019 to 2025Bar chart with a peak of 4 patents in 2025.peak 42019: 3 patents20192020: 1 patents20202021: 2 patents20212022: 2 patents20222025: 4 patents2025

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
12441812 Methods of treating cancer by administering tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules Maria Amann, Peter Bruenker, Christina Claus, Claudia Ferrara Koller, Sandra Grau-Richards +4 more 2025-10-14
12391757 Bispecific antibodies specific for PD1 and TIM3 Laura Codarri-Deak, Georg Fertig, Jens Fischer, Christian Klein, Valeria Lifke +7 more 2025-08-19
12240911 Bispecific antibodies specific for OX40 Maria Amann, Peter Bruenker, Christina Claus, Claudia Ferrara Koller, Sandra Grau-Richards +3 more 2025-03-04
12202870 Antigen binding molecules comprising a trimeric TNF family ligand and encoding polynucleotides thereof Maria Amann, Peter Bruenker, Christina Claus, Claudia Ferrara Koller, Sandra Grau-Richards +3 more 2025-01-21
11306154 Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer Maria Amann, Peter Bruenker, Christina Claus, Claudia Ferrara Koller, Sandra Grau-Richards +4 more 2022-04-19
11267903 Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer Maria Amann, Peter Bruenker, Christina Claus, Claudia Ferrara Koller, Sandra Grau-Richards +4 more 2022-03-08
11149083 Antigen binding molecules comprising a TNF family ligand trimer and a Tenascin binding moiety Maria Amann, Peter Bruenker, Christina Claus, Claudia Ferrara Koller, Sandra Grau-Richards +3 more 2021-10-19
11130810 Bispecific antibodies specific for PD1 and TIM3 Laura Codarri-Deak, Georg Fertig, Jens Fischer, Christian Klein, Valeria Lifke +7 more 2021-09-28
10526413 Bispecific antibodies specific for OX40 Maria Amann, Peter Bruenker, Christina Claus, Claudia Ferrara Koller, Sandra Grau-Richards +3 more 2020-01-07
10464981 Tumor necrosis factor (TNF) family ligand trimer-containing antigen binding molecules Maria Amann, Peter Bruenker, Christina Claus, Claudia Ferrara Koller, Sandra Grau-Richards +3 more 2019-11-05
10392445 Tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules Maria Amann, Peter Bruenker, Christina Claus, Claudia Ferrara Koller, Sandra Grau-Richards +4 more 2019-08-27
10287352 Bispecific antibodies specific for PD1 and TIM3 Laura Codarri-Deak, Georg Fertig, Jens Fischer, Christian Klein, Valeria Lifke +7 more 2019-05-14